SIRT and chemotherapy in unresectable iCCA: Ready to take off

Irene Bargellini¹, Lorenza Rimassa^{2

3}, Gianluca Masi^{4

5}

Affiliations

¹ Diagnostic and Interventional Radiology Unit, Candiolo Cancer Institute, Turin, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.
³ Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.
⁴ Medical Oncology Unit, University Hospital of Pisa, Pisa, Italy.
⁵ Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Comment

Irene Bargellini et al. Hepatology. 2024.

. 2024 Jan 1;79(1):9-11.

doi: 10.1097/HEP.0000000000000561. Epub 2023 Aug 9.

Irene Bargellini¹, Lorenza Rimassa^{2

3}, Gianluca Masi^{4

5}

¹ Diagnostic and Interventional Radiology Unit, Candiolo Cancer Institute, Turin, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.
³ Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.
⁴ Medical Oncology Unit, University Hospital of Pisa, Pisa, Italy.
⁵ Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

No abstract available

Comment on

Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials.
Edeline J, Bridgewater J, Campillo-Gimenez B, Neveu E, Phelip JM, Neuzillet C, Boudjema K, Rolland Y, Valle JW, Garin E, Malka D, Lamarca A. Edeline J, et al. Hepatology. 2024 Jan 1;79(1):96-106. doi: 10.1097/HEP.0000000000000544. Epub 2023 Jul 25. Hepatology. 2024. PMID: 37505216

1. Edeline J, Bridgewater J, Campillo-Gimenez B, Neveu E, Phelip JM, Neuzillet C, et al. Chemotherapy with or without Selective Internal Radiation Therapy for intrahepatic cholangiocarcinoma: data from clinical trials. Hepatology. 2023. doi: 10.1097/HEP.0000000000000544. [Online ahead of print]. - DOI
1. Robinson TJ, Du L, Matsuoka L, Sze DY, Kennedy AS, Gandhi RT, et al. Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry. J Vasc Interv Radiol. 2023;34:694–701.e3.
1. Zhen Y, Liu B, Chang Z, Ren H, Liu Z, Zheng J. A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma. Onco Targets Ther. 2019;12:4489–98.
1. Edeline J, Touchefeu Y, Guiu B, Farge O, Tougeron D, Baumgaertner I, et al. Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6:51–59.
1. Cheng B, Villalobos A, Sethi I, Wagstaff W, Galt J, Brandon D, et al. Determination of Tumor dose response thresholds in patients with chemorefractory intrahepatic cholangiocarcinoma treated with resin and Glass-based Y90 Radioembolization. Cardiovasc Intervent Radiol. 2021;44:1194–1203.